Human hepatitis B immunoglobulin (Nanyue Biopharming)

人乙型肝炎免疫球蛋白（南岳生物制药）

Report date: 2022/03/04 09:31:30

Base Information

Drug NameHuman hepatitis B immunoglobulin (Nanyue Biopharming)
Drug Alias Name人乙肝免疫球蛋白（南岳生物制药）
ClassificationBiologics > Blood componentsBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionImmunoglobulin replacements
TargetsImmunoglobulin
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsHepatitis B
Approved Indications in ChinaHepatitis B
Original Approved Country/TerritoryMainland China
Original Approved Date2001/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeJ06BB04
Related LinksN/A